Immunosuppressants for the Treatment of Psoriasis

Journal of Nihon University Medical Association
doi 10.4264/numa.76.1_31
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Nihon University Medical Association

Related search

Adalimumab for the Treatment of Psoriasis

Health Technology Assessment
MedicineHealth Policy
2009English

Infliximab for the Treatment of Plaque Psoriasis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

A Novel Vehicle for the Treatment of Psoriasis

Dermatologic Therapy
DermatologyMedicine
2019English

Monoclonal Antibodies for the Treatment of Plaque Psoriasis

Prescriber
Pharmacology
2019English

Dimethyl Fumarate for the Treatment of Plaque Psoriasis

Prescriber
Pharmacology
2018English

From the Medical Board of the National Psoriasis Foundation: Treatment Targets for Plaque Psoriasis

Journal of the American Academy of Dermatology
Dermatology
2017English

Infliximab for the Treatment of Adults With Psoriasis

Health Technology Assessment
MedicineHealth Policy
2009English

Treatment of Psoriasis.

BMJ
1966English

Tofacitinib for the Treatment of Psoriasis and Psoriatic Arthritis

Expert Review of Clinical Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy